Cite
HARVARD Citation
Pemmaraju, N. et al. (2022). CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights. Leukemia research. p. . [Online].